Oregon Health Sciences University

Portland, Oregon 98239

26 studies enrolling now · 250 studies all time

What they study most

AAA, AAA - Abdominal Aortic Aneurysm, ADHF, ALS, ANCA Associated Vasculitis (AAV), Abortion Seekers, Acromegaly, Acute Ischemic Stroke, Acute Liver Failure, Acute Lung Injury, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)

Studies at this site

• Precision-Based Genomics in Prostate Cancer — Recruiting now
• ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis — Recruiting now
• Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure — Recruiting now
• Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network — Recruiting now
• Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates — Recruiting now
• A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines — Recruiting now
• Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study — Recruiting now
• Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis — Recruiting now
• Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
• Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children — Recruiting now
• Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX) — Recruiting now
• Asciminib Roll-over Study — Recruiting now
• Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis — Recruiting now
• A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma — Recruiting now
• A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) — Recruiting now
• Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA — Recruiting now
• Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB) — Recruiting now
• Serranator POINT FORCE Registry — Recruiting now
• Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO) — Recruiting now
• Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease — Recruiting now
• cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease — Recruiting now
• Early Amiodarone in Shockable Cardiac Arrest — Recruiting now
• CAR-T Long Term Follow Up (LTFU) Study — Recruiting now
• Comparative Effectiveness of Cryoablation Versus Steroid and Lidocaine Alone for Treatment of Morton's Neuroma — Recruiting now
• A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators — Recruiting now
• Effect of Abdominal Wall Injections on Abdominal Pain — Recruiting now
• Mitral Valve Screening Survey — Recruiting now
• MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles — Recruiting now
• JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization — Recruiting now
• Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies — Running, not enrolling
• Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab. — Running, not enrolling
• First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria — Completed
• Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events — Running, not enrolling
• Rethinking Early Airway Clearence Therapies — Starting soon
• Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma — Completed
• Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator — Completed
• An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) — Running, not enrolling
• A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP — Running, not enrolling
• North American Prodromal Synucleinopathy Consortium Stage 2 — Enrolling by invitation
• A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy. — Completed
• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• The PROMISE Pediatric Study 6 to 11 Years Old — Completed
• Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation — Completed
• Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment — Running, not enrolling
• CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung — Running, not enrolling
• FT819 in Subjects With B-cell Malignancies — Running, not enrolling
• Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial) — Running, not enrolling
• Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring — Completed
• Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam — Completed
• PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma — Stopped early